The debate persists about the inflammatory or tumoral, benign or malignant nature of the Inflammatory myofibroblastic tumors (TMI). Radioclinically, they can mimic a malignant neoplasm, although they are classified as intermediate by the World Health Organization (WHO). The diagnosis is almost always made by pathological examination. The treatment is poorly codified but the management is usually surgical. The removal of these tumors is a challenge when the mass is developed at the expense of or in the vicinity of noble organs. Several therapies have been tested to overcome the limitations of surgery, the results are variable. These tumors rarely affect the digestive tract. We propose the study of a case of myofibroblastic tumor developed at the expense of the omentum, five months after a cesarean section, in order to try to determine if it is a rare complication of the postpartum or a fortuitous combination.

Introduction : Quality of life (QOL) has become an important part of the medical decision along with the efficacy and safety of treatment. Cancer is a chronic disease that affects the quality of life of patients from which the idea of evaluating the QOL of patients treated in the service. This is a descriptive cross-sectional study carried out at the Mohamed VI center for the treatment of cancers of Ibn Rochd Hospital of Casablanca over a period of one year. Results : In our study, the QOL was evaluated by the Moroccan Arabic dialect version adapted and validated to our context of the survey (FACT), the servey is divided into 5 modules (localization of the cancer): breast, cervix, endometrium, ovary and vulva . Based on the results of this study, we can conclude that the localization of the cancer does not affect the QOL of the patients, besides the concept of the quality of life of the cancer patients is a primordial element, and useful for the choice of the patients therapeutic decisions, the evaluation of the different anticancer treatments and still for the rehabilitation of the patients with cancer.